Search results
Gamechanging blood test predicts breast cancer relapse up to three years early
Daily Express· 5 days agoAn “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before...
Drug users offer insight into record Buffalo-Niagara overdose deaths: 'People are trapped'
The Buffalo News· 4 days agoNathaniel Carson’s oldest daughter got married last year but Carson couldn’t go. Then Carson hurt...
Why Kelly Osbourne Says Her Body Is “Pickled From All the Drugs and Alcohol” - E! Online
E! Online· 23 hours agoKelly Osbourne joked that her histories of drug and alcohol addictions may have provided one major...
Judge blocks WV from 'outrageous' forcing parolees out of uncertified recovery houses
The Charleston Gazette· 3 hours agoCalling state oversight of people recovering from substance use disorder “outrageous,” a federal...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 4 days agoAt a median follow-up of 21.8 months, the 12-month estimated PFS rates were 71% with BPd versus 51%...
Hunter Biden's Attorneys Prepare to Attack Government's Crediblity
The New York Sun· 23 hours agoMr. Hines asked Ms. Jensen to read from a prepared document that contained hundreds of personal text...
GSK blood cancer drug nearly halves risk of death in late-stage trial
AOL· 4 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according ...
Antidepressant withdrawal affects one in six people
BBC News· 7 hours agoOne out of every six people have symptoms when they stop taking antidepressants - fewer than previously thought, a review of previous studies suggests....
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 6 days agoBristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration for...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 3 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...